<?xml version="1.0"?>

<rss version="2.0">
   <channel>
      <title><![CDATA[releases feed for Mitem]]></title>
      <link>http://www.realwire.com/</link>
      <description><![CDATA[Most recent 15 articles distributed for Mitem by RealWire]]></description>
      <language>en-gb</language>
      <lastBuildDate>Sat, 25 May 2013 00:00:01 +0100</lastBuildDate>
      <docs>http://blogs.law.harvard.edu/tech/rss</docs>
      <category>News</category>
      <managingEditor>enquiries@realwire.com (RealWire)</managingEditor>
      <copyright>Copyright (c) 2013 Realwire Limited</copyright>
	  <ttl>60</ttl>
      <image>
        <title>RealWire</title>
        <url>http://www.realwire.com/images/headLogo.gif</url>
        <link>http://www.realwire.com/</link>
      </image>

      <item>
         <title>SEP, The Pan European Specialty Urology Company, Acquires Mitem&#174;</title>
		 <link>http://www.realwire.com/releases/SEP-The-Pan-European-Specialty-Urology-Company-Acquires-Mitem</link>
         <description><![CDATA[Speciality European Pharma Limited (SEP), the pan European urology focused specialty pharmaceutical company, is pleased to announce its acquisition of the product Mitem&#174; from Curasan AG. Mitem is currently sold in Germany. SEP takes over German distribution rights and plans to introduce the product into other European markets once Marketing Authorisations are granted.Mitem is an injectable mitomycin product used either on its own or in combination with other therapies in the treatment of a range...

Source: RealWire]]></description>
         <pubDate>Tue, 05 Oct 2010 09:27:00 +0100</pubDate>
		 <guid isPermaLink="true">http://www.realwire.com/releases/SEP-The-Pan-European-Specialty-Urology-Company-Acquires-Mitem</guid>
      </item>
  
   </channel>
</rss>
